Form 4: Globus Medical Director Sells Shares After Option Exercise

A director at Globus Medical Inc. exercised stock options and subsequently sold 25,000 Class A Common Stock shares.

Summary

• David D. Davidar, a Director of Globus Medical Inc. (GMED), reported transactions involving Class A Common Stock.
• On November 12, 2025, Davidar exercised stock options to acquire 25,000 shares of Class A Common Stock at an exercise price of $25.52 per share.
• Immediately following the option exercise on the same date, Davidar sold 25,000 shares of Class A Common Stock at a weighted average price of $86.0002 per share.
• The sale price ranged from $86.00 to $86.01 per share.
• After these transactions, Davidar directly beneficially owns 516,275 shares of Class A Common Stock.
• Additionally, 165,967 shares are indirectly beneficially owned through the Davidar Family Irrevocable Trust U/A 8/6/09, for which the reporting person's spouse is trustee.
• The exercised options were granted on January 25, 2016, and were fully vested, with an expiration date of January 25, 2026.

Sentiment

Score: 5

Explanation: A director exercised vested stock options and immediately sold the acquired shares, a common liquidity or tax planning event. This is generally considered a neutral event for the company's outlook.

Negatives

• An insider sale, even if routine, can sometimes be perceived as a lack of conviction by the market, though often it is for personal liquidity or tax planning.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance.

Industry Context

This is a routine insider transaction and does not provide specific insights into broader industry trends or competitive landscape.

Related Party Transactions

• 165,967 shares are indirectly beneficially owned through the Davidar Family Irrevocable Trust U/A 8/6/09, for the benefit of the reporting person's spouse and children, with the spouse as trustee.

Stakeholder Impact

• Shareholders may note the insider sale, but given the context of option exercise, it is unlikely to significantly alter perceptions of company fundamentals.

Key Dates

Recommendation

The filing reports a routine insider transaction where a director exercised vested stock options and subsequently sold the acquired shares. This type of transaction is often for personal liquidity or tax planning and does not typically indicate a change in the company's fundamental outlook or a strong directional signal for the stock. Therefore, a 'hold' recommendation is appropriate based solely on this filing.

Keywords

Globus Medical, GMED, Insider Trading, Form 4, Stock Option Exercise, Director Sale, Equity Transaction